887375-67-9 Usage
Uses
Used in Ophthalmology:
K115 is used as a monotherapy treatment for glaucoma and ocular hypertension when other drugs cannot be used or are not effective. It is administered twice daily and has shown promising results in clinical trials as a combination therapy with other glaucoma drugs for the treatment of primary open-angle glaucoma or ocular hypertension.
Used in Diabetic Retinopathy and Diabetic Macular Edema Treatment:
The Kowa Company is currently pursuing trials focused on the use of K115 for the treatment of diabetic retinopathy and diabetic macular edema, indicating its potential application in the field of diabetic eye diseases.
Synthesis
While initial synthetic routes to ripasudil were carried out via a
stepwise functionalization of 4-fluoroisoquinoline-5-sulfonyl
chloride (238), more recent reports describe an efficient
route to ripasudil employing a late stage-coupling of Boc-diazepane
(237) with 4-fluoroisoquinoline-5-sulfonyl chloride (238),
enabling synthesis on multi-kilogram scale and isolation of the
drug in high purity. This optimized route
to ripasudil begins with 2-nitrobenzene sulfonyl chloride (NsCl)-
mediated protection of (S)-2-amino-1-propanol (234) in 82% yield.
In this case, use of the NaHCO3/THF/H2O conditions were essential
for preventing bis-nosylation.228 Alcohol activation with methanesulfonyl
chloride (MsCl) in N-methyl morpholine (NMM) took
place smoothly to give the corresponding mesylate 235 in 91%
yield. Direct mesylate displacement with 3-aminopropanol and
subsequent amine protection as the carbamate ((Boc)2O) in a
one-pot fashion provided the corresponding Boc-amino propanol
product 236 in 95% yield over 2 steps. With the acyclic diazepane
precursor 236 in hand, employment of the intramolecular
Fukuyama-Mitsunobu N-alkyl cyclization conditions (diisopropyl
azodicarboxylate (DIAD)/PPh3) allowed generation of the diazepane
in 75% yield. Nosyl group cleavage with thiophenol/K2CO3
provided the Boc-diazepane 237 in 65% overall yield and 98% purity
following a pH-controlled aqueous workup. Finally, 4-fluoroisoquinoline-
5-sulfonyl chloride (238)—prepared via subjection of 4-
fluoroisoquinoline (239) to sulfur trioxide and sulfuric
acid followed by treatment with thionyl chloride and finally 4 N
HCl in ethyl acetate—was involved in a 1-pot, two-step procedure
in which this sulfonyl chloride was coupled with diazepane 237
(TEA/MeCN) to access the ripasudil framework in quantitative
yield. Synthesis of the final drug target by deprotection with 4 M
HCl in ethyl acetate followed by neutralization with aqueous
sodium hydroxide provided the free base of ripasudil in 93% yield
and 99.8% purity. Conversion to the more stable hydrochloride
dihydrate form could be performed by treatment of the free base
with 1 M HCl/EtOH and subsequent heating of the hydrochloride
in H2O/acetone to provide ripasudil hydrochloride dihydrate XXIX
in 83% yield.
in vivo
in optic nerve crush (nc) c57bl/6 mice model, oral administration of k-115 (1 mg/kg/d) increased 34 ± 3% survival of rgcs after nc [2].
references
shimokawa h, takeshita a. rho-kinase is an important therapeutic target in cardiovascular medicine[j]. arteriosclerosis, thrombosis, and vascular biology, 2005, 25(9): 1767-1775.yamamoto k, maruyama k, himori n, et al. the novel rho kinase (rock) inhibitor k-115: a new candidate drug for neuroprotective treatment in glaucomanovel rho kinase inhibitor[j]. investigative ophthalmology & visual science, 2014, 55(11): 7126-7136.tanihara h, inoue t, yamamoto t, et al. phase 1
Check Digit Verification of cas no
The CAS Registry Mumber 887375-67-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,7,3,7 and 5 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 887375-67:
(8*8)+(7*8)+(6*7)+(5*3)+(4*7)+(3*5)+(2*6)+(1*7)=239
239 % 10 = 9
So 887375-67-9 is a valid CAS Registry Number.
